Patents by Inventor Wol-Young Kim

Wol-Young Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic amine derivative and pharmaceutical composition comprising same
    Patent number: 12227498
    Abstract: The present disclosure relates to a novel heterocyclic amine derivative represented by the following Chemical Formula 1 and a pharmaceutical composition comprising the same, and the compound according to the present disclosure can be usefully used for the prevention or treatment of autoimmune diseases or cancers. wherein, in Chemical Formula 1, R1, R2, X1, X2, L, Y, A and B are the same as defined in the specification.
    Type: Grant
    Filed: August 27, 2019
    Date of Patent: February 18, 2025
    Assignee: Daewoong Pharmaceutical Co., Ltd.
    Inventors: Wol Young Kim, Yeon Im Lee, Youn Jung Yoon, Joon Seok Park, Deok Ki Eom, Keuk-Chan Bang, Jaehyun Jung
  • METHOD FOR PREPARATION OF HETEROCYCLICAMINE DERIVATIVES
    Publication number: 20230094404
    Abstract: The present disclosure relates to a method for preparing a heterocyclic amine derivative, and the preparation method according to the present disclosure has an advantage that a heterocyclic amine derivative having a reduced impurity content can be prepared in a high yield.
    Type: Application
    Filed: February 26, 2021
    Publication date: March 30, 2023
    Inventors: Wol Young Kim, Qing Ri Li, Deok Ki Eom, Hyae Jung Hyun, Joon Seok Park
  • NOVEL HETEROCYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
    Publication number: 20220064155
    Abstract: The present disclosure relates to a novel heterocyclic amine derivative represented by the following Chemical Formula 1 and a pharmaceutical composition comprising the same, and the compound according to the present disclosure can be usefully used for the prevention or treatment of autoimmune diseases or cancers. wherein, in Chemical Formula 1, R1, R2, X1, X2, L, Y, A and B are the same as defined in the specification.
    Type: Application
    Filed: August 27, 2019
    Publication date: March 3, 2022
    Inventors: Wol Young Kim, Yeon Im Lee, Youn Jung Yoon, Joon Seok Park, Deok Ki Eom, Keuk-Chan Bang, Jaehyun Jung
  • Phenylpyridine derivative and pharmaceutical composition comprising the same
    Patent number: 11149019
    Abstract: The present disclosure relates to a novel phenylpyridine derivative represented by Chemical Formula 1 and a pharmaceutical composition comprising the same, and the compound according to the present disclosure can be usefully used for the prevention or treatment of autoimmune diseases or cancers.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: October 19, 2021
    Assignee: Daewoong Pharmaceutical Co., Ltd.
    Inventors: Wol-Young Kim, Jung-eun Park, Keuk-Chan Bang, Joon-Seok Park
  • Novel Phenylpyridine Derivative and Pharmaceutical Composition Comprising the Same
    Publication number: 20200223821
    Abstract: The present disclosure relates to a novel phenylpyridine derivative represented by Chemical Formula 1 and a pharmaceutical composition comprising the same, and the compound according to the present disclosure can be usefully used for the prevention or treatment of autoimmune diseases or cancers.
    Type: Application
    Filed: October 11, 2018
    Publication date: July 16, 2020
    Inventors: Wol-Young Kim, Jung-eun Park, Keuk-Chan Bang, Joon-Seok Park
  • PROCESS FOR PREPARING ERTAPENEM-CONTAINING LYOPHILIZED FORMULATION
    Publication number: 20170224660
    Abstract: The present invention provides a process for preparing an ertapenem-containing lyophilized formulation, comprising the use of hydroxypropyl p-cyclodextrin as both a cryoprotective agent and a stabilizing agent.
    Type: Application
    Filed: July 28, 2015
    Publication date: August 10, 2017
    Applicant: DAEWOONG PHARMACEUTICAL CO., LTD.
    Inventors: Bong-Yong LEE, Hee-Kyoon YOON, Wol-Young KIM, Jeong-Taek SHIN
  • Process for preparing ertapenem-containing lyophilized formulation
    Patent number: 9717708
    Abstract: The present invention provides a process for preparing an ertapenem-containing lyophilized formulation, comprising the use of hydroxypropyl ?-cyclodextrin as both a cryoprotective agent and a stabilizing agent.
    Type: Grant
    Filed: July 28, 2015
    Date of Patent: August 1, 2017
    Assignee: DAEWOONG PHARMACEUTICAL CO., LTD.
    Inventors: Bong-Yong Lee, Hee-Kyoon Yoon, Wol-Young Kim, Jeong-Taek Shin
  • Method for selectively crystallizing a Z isomer of iopromide
    Patent number: 8541620
    Abstract: The present invention relates to a method for selectively crystallizing Z isomer of iopromide of formula (I) comprising a) dissolving a crude iopromide comprising a mixture of E and Z isomers or a concentrate thereof in an alcohol, and b) heating the resulting alcohol solution to obtain crystalline of Z isomer of iopromide; and a method for preparing a composition comprising the crystalline Z isomer of iopromide.
    Type: Grant
    Filed: October 21, 2009
    Date of Patent: September 24, 2013
    Assignee: Daewoong Pharmaceutical Co., Ltd.
    Inventors: Soo-Jin Choi, Byung-Goo Lee, Han-Kuk Lee, Young-Mook Lim, Wol-Young Kim, Joon-Hwan Lee
  • METHOD FOR SELECTIVELY CRYSTALLIZING A Z ISOMER OF IOPROMIDE
    Publication number: 20110245347
    Abstract: The present invention relates to a method for selectively crystallizing Z isomer of iopromide of formula (I) comprising a) dissolving a crude iopromide comprising a mixture of E and Z isomers or a concentrate thereof in an alcohol, and b) heating the resulting alcohol solution to obtain crystalline of Z isomer of iopromide; and a method for preparing a composition comprising the crystalline Z isomer of iopromide.
    Type: Application
    Filed: October 12, 2009
    Publication date: October 6, 2011
    Applicant: DAEWOONG PHARMACEUTICAL CO., LTD.
    Inventors: Soo-Jin Choi, Byung-Goo Lee, Han-Kuk Lee, Young-Mook Lim, Wol-Young Kim, Joon-Hwan Lee